← Search

Data · dataset · 2019

JCEM-jc-2019-01933-FROMMER-SUPPLEMENTAL_MATERIAL

Listed in DataCite

Context : The structure of the human leucocyte antigen (HLA) peptide-binding clefts strongly contributes to monoglandular and polyglandular autoimmunity (AP).

Description

Objective : To investigate the impact of amino acid polymorphisms on the peptide binding interactions within HLA class II and its association with AP Design: immunogenetic study Setting : Tertiary referral center for autoimmune endocrine diseases Subjects : 587 subjects with AP, autoimmune thyroid disease (AITD), type 1 diabetes (T1D) and healthy unrelated controls were typed for HLA class II.

Methods

Read the rest (3 more)

Amino acids within the peptide binding cleft that are encoded by HLA class II exon 2 were listed for all codon positions in all subjects. Overall comparisons between disease and control groups with respect to allele distribution at a given locus were performed by assembling rare alleles applying an exact Freeman Halton contingency table test with Monte-Carlo p values based on 150,000 samples. Results : The Montecarlo Exact Fisher Test demonstrated marked differences in all three Loci, DQA1 , DQB1 , DRB1 (p<0.0001) between AP versus both AITD and controls, as well as between AP type II (Addison’s disease as major endocrine component) and AP type III (T1D + AITD).

Differences were also noted between AP and T1D pertaining to the DRB1 allele (p<0.041). The following seven amino acid positions DRB1-13, DRB1-26, DRB1-71, DRB1-74, DQA1-47, DQA1-56, and DQB1-57 significantly contributed to AP. Five positions in DQA1 (11, 47, 50, 56, and 69) completely correlated (p<0.0001).

Conclusion : Amino acid polymorphisms within HLA class II exon 2 mediate the AP risk and differentiate between thyroid and polyglandular autoimmunity.

Links

Topics

From keywords
Genetics
Inferred from text
Disease 75% · Tabular 65%

Related

Provenance · 2 source records, 16 field assertions
SourceKeyLast seenRaw
DataCite10.6084/m9.figshare.970294714 d agoJSON v1
DataCite10.6084/m9.figshare.9702947.v514 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · DataCiteconnector:datacite@1.0.0/data/attributes/rightsList
byte_sizesource · DataCiteconnector:datacite@1.0.0
concepts[disease].local:disease:diseaseenrichment · DataCitekeyword-concept-rules@1.0.0title+description (75%)
concepts[field].fos:basic-medicinesource · DataCiteconnector:datacite@1.0.0
concepts[field].fos:basic-medicinesource · DataCiteconnector:datacite@1.0.0
concepts[field].fos:biological-sciencessource · DataCiteconnector:datacite@1.0.0
concepts[field].fos:biological-sciencessource · DataCiteconnector:datacite@1.0.0
concepts[field].fos:clinical-medicinesource · DataCiteconnector:datacite@1.0.0
concepts[field].fos:clinical-medicinesource · DataCiteconnector:datacite@1.0.0
concepts[modality].local:modality:tabularenrichment · DataCitekeyword-concept-rules@1.0.0title+description (65%)
created_datesource · DataCiteconnector:datacite@1.0.0
descriptionsource · DataCiteconnector:datacite@1.0.0/data/attributes/descriptions
licensesource · DataCiteconnector:datacite@1.0.0/data/attributes/rightsList
publication_datesource · DataCiteconnector:datacite@1.0.0/data/attributes/dates
titlesource · DataCiteconnector:datacite@1.0.0/data/attributes/titles/0/title
updated_datesource · DataCiteconnector:datacite@1.0.0